logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Trends & Strategies
  • Life Science & Technology Weekly 124 – Everest Enters $224 Million Two-Drug China Partnership with Arena

Life Science & Technology Weekly 124 – Everest Enters $224 Million Two-Drug China Partnership with Arena

NAI Life Science Weekly - www.nai500.com
Published on: Dec 7, 2017
Author: Editor
  • Share article:

Check www.nai500.com for more investment opportunities

Click here to find more details

This is NAI’s new Life Science and Technology Weekly. We will be covering the latest news in life science, pharmaceutical, biotech and technology sectors every week. To continue to receive NAI’s Life Science and Technology Weekly, please click Here to subscribe.

Biotechnology Life Science Technology

Related Posts

高股息医疗股怎么选?强生与美敦力的优势与挑战

Healthcare Expenditures Continue to Grow, Three Leading Stocks Lead the 2026 Investment Race

如何通过一只ETF投资整个生物技术行业?

iShares Semiconductor ETF Balances Growth and Cyclical Risk Amid Cloud Capex Surge

英伟达之后,博通将成为下一个2万亿美元芯片巨头

NVIDIA Leads $40 Billion Corporate Bond Issuance Surge, Valuation Draws Attention Ahead of Shareholder Meeting

美股新牛市逻辑形成?摩根士丹利详解七大支撑因素

Morgan Stanley Says Era of “Computing Power + Electric Power” Convergence Has Begun

分析师称Palo Alto业绩“全方位亮眼”,目标价看至235美元

Super Bull Admits to Underestimating Current Rally as Exceptional Earnings Momentum Drives Market’s Continued Bull Run

NVRO Metals Signs Heads of Agreement With Transamine for Proposed Copper Cathode Offtake and Financing Package of up to US$25 Million

Related News

Is Marvell Still a Buy After Its 10% Surge and Pullback?

8 hours ago.

Healthcare Expenditures Continue to Grow, Three Leading Stocks Lead the 2026 Investment Race

14 hours ago.

iShares Semiconductor ETF Balances Growth and Cyclical Risk Amid Cloud Capex Surge

15 hours ago.

NVIDIA Leads $40 Billion Corporate Bond Issuance Surge, Valuation Draws Attention Ahead of Shareholder Meeting

16 hours ago.

Top Stories

Can SpaceX Dethrone Amazon? The $2.4 Trillion Valuation Bubble Debate
Technology

Can SpaceX Dethrone Amazon? The $2.4 Trillion Valuation Bubble Debate

英伟达之后,博通将成为下一个2万亿美元芯片巨头
Technology

NVIDIA Leads $40 Billion Corporate Bond Issuance Surge, Valuation Draws Attention Ahead of Shareholder Meeting

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada